Thermo Fisher Scientific Inc (TMO)
Working capital turnover
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 44,556,000 | 43,736,000 | 43,212,000 | 42,898,000 | 42,879,000 | 42,370,000 | 42,346,000 | 42,492,000 | 42,857,000 | 43,421,000 | 43,524,000 | 43,807,000 | 44,915,000 | 44,167,000 | 42,820,000 | 41,123,000 | 39,211,000 | 39,059,000 | 38,250,000 | 35,894,000 |
| Total current assets | US$ in thousands | 28,707,000 | 22,295,000 | 24,584,000 | 23,378,000 | 22,137,000 | 23,783,000 | 25,476,000 | 23,640,000 | 24,589,000 | 23,092,000 | 19,995,000 | 20,209,000 | 25,229,000 | 19,299,000 | 18,100,000 | 18,776,000 | 20,113,000 | 24,724,000 | 19,260,000 | 17,685,000 |
| Total current liabilities | US$ in thousands | 15,189,000 | 14,888,000 | 12,718,000 | 13,174,000 | 13,332,000 | 14,601,000 | 14,772,000 | 13,937,000 | 14,012,000 | 14,158,000 | 14,112,000 | 15,884,000 | 17,010,000 | 11,118,000 | 10,997,000 | 12,070,000 | 13,436,000 | 7,753,000 | 6,925,000 | 6,995,000 |
| Working capital turnover | 3.30 | 5.90 | 3.64 | 4.20 | 4.87 | 4.61 | 3.96 | 4.38 | 4.05 | 4.86 | 7.40 | 10.13 | 5.46 | 5.40 | 6.03 | 6.13 | 5.87 | 2.30 | 3.10 | 3.36 |
December 31, 2025 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $44,556,000K ÷ ($28,707,000K – $15,189,000K)
= 3.30
Peer comparison
Dec 31, 2025
Company name
Symbol
Working capital turnover
Thermo Fisher Scientific Inc
TMO
3.30
Agilent Technologies Inc
A
3.09
Danaher Corporation
DHR
4.13
See also:
Thermo Fisher Scientific Inc Working Capital Turnover (Quarterly Data)